← Back to Vaccine Database

SCT1000

Virus-like particle vaccine · VDDBV0690

Target & Classification

HPVHuman papillomavirus
Virus-like particle vaccine
Recurrent Human Papillomavirus Type 16 Associated Cancer; HPV16 Associated Cervical Cancer
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT05060484 Phase 2Recurrent Human Papillomavirus Type 16 Associated Cancer
NCT04921111 Phase 1HPV16 Associated Cervical Cancer